Glider | $4,000,000 | (Apr 18, 2025)
Graze Social | $1,000,000 | (Apr 18, 2025)
Nyobolt | $30,000,000 | (Apr 18, 2025)
Certified by Founder
Lodge
Pathalys Pharma
start up
United States
- Raleigh, North Carolina
- 07/02/2023
- Unknown
- $150,000,000
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
- Industry Biotechnology Research
- Website https://pathalys.com/
- LinkedIn https://www.linkedin.com/company/pathalys/
Booked it | $3,316,375 | (Apr 18, 2025)
FOTENIX | $2,785,755 | (Apr 18, 2025)
Exaforce Inc. | $75,000,000 | (Apr 18, 2025)
Pillar Security | $9,000,000 | (Apr 18, 2025)
Cy4Data Labs | $10,000,000 | (Apr 18, 2025)
Meadow | $14,000,000 | (Apr 18, 2025)
Trellis Health | $1,800,000 | (Apr 18, 2025)
RISA | $3,500,000 | (Apr 18, 2025)
Vizzy | B Corp™ | $4,841,908 | (Apr 18, 2025)
Assort Health | $26,000,000 | (Apr 18, 2025)